Skip to content
TrustList
Leaps by Bayer logo
Investor

Leaps by Bayer

Bayer's venture investment arm backing life-science breakthroughs in health and agriculture

Leaps by Bayer cover

About Leaps by Bayer

Bayer's impact investing arm, Leaps by Bayer, buys minority stakes in science-led teams working in human health and agriculture. The unit says its aim is to shift the paradigm with transformative therapies and technologies that could affect millions of people.

Ten challenges

The organising idea is a set of ten huge challenges facing humanity, which the unit calls Leaps. It says some people call such challenges impossible, and it describes its portfolio as teams working to break through them. The areas it lists include food loss, farmer livelihoods, healthier crop varieties, autoimmune disease, chronic inflammation and the environmental impact of farming.

Collaboration and speed

The unit says its strategic investments draw on Bayer's long expertise in human health and agriculture to enable collaboration and speed. It describes working with the brightest minds in healthcare and agriculture, and it says each investment is a team invested in the same vision. It stresses that breakthroughs come from many people working together rather than from a lone hero. The unit says it takes more than a lone hero to break through what some call impossible, so it pairs its equity with the scientific expertise of Bayer.

Annual reviews and reporting

The unit publishes an annual review that summarises milestones reached by its team and portfolio, its investment highlights and its community engagement. The most recent review reflects on a year of progress, growth and stories that the unit says point toward what comes next. It describes its work as minority equity investment combined with public reporting on progress against its ten challenges.

TrustList summary

Leaps by Bayer is the impact investment unit of Bayer. It takes minority equity stakes in teams pursuing fundamental advances in the life sciences, across human health and agriculture.

Its organising idea is a set of ten large challenges, which it calls leaps. It says it wants to combine Bayer's long experience in health and agriculture with collaboration and speed.

Services

  • Minority equity investment: stakes in companies working on transformative therapies and technologies.
  • Health focus: includes autoimmune diseases and chronic inflammation.
  • Agriculture focus: includes next-generation healthy crops, crop and food loss, and the livelihoods of farmers.
  • Environmental focus: tackling the environmental impact of agriculture.
  • Annual review: publishes a yearly summary of milestones, investments and community activities.

Clients

Science-led teams in healthcare and agriculture, with strategic investors and partners across both fields.

Key facts

  • Parent company: Bayer
  • Challenges targeted: Ten

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

  • Collaboration
  • It
  • Science
  • Sport
  • Agriculture

Ask TrustList to introduce you to Leaps by Bayer

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Leaps by Bayer

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Leaps by Bayer.

Leaps by Bayer alternatives

Similar listings buyers compare against this one.

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Venture capital firm investing in climate tech, biotech, aerospace and next-generation computing companies

Full-stack venture fund backing founders from seed stage through to growth and impact

Healthcare venture capital firm investing in therapeutics and discovery platforms for unmet medical needs

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

A Toronto venture firm investing in early-stage Canadian B2B technology companies

TF Capital is a Shanghai-based investor backing early-stage biotech companies in China

Venture firm investing in tech startups and building their engineering teams in Latin America